Immunotherapy before lung cancer surgery shows promise in early trial
Disease control
Completed
This study tested the immunotherapy drug pembrolizumab in 35 people with early-stage non-small cell lung cancer. Participants received the drug before and after surgery to see if it could help the immune system attack cancer cells. The main goal was to check if surgery could stil…
Phase: PHASE2 • Sponsor: Neal Ready MD PhD • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC